Related Experiment Video
Updated: Jun 20, 2026

07:46
Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration
Published on: June 18, 2018
12.0K
Quantitative Susceptibility Mapping Changes Relate to Gait Issues in Parkinson's Disease
Nabeela Nathoo1, Myrlene Gee1, Krista Nelles1
1Department of Medicine (Neurology), University of Alberta, Edmonton, Alberta, Canada.
Summary
Quantitative susceptibility mapping reveals higher iron in specific brain regions associated with gait issues in Parkinson's disease (PD) patients, including freezing of gait (FOG). This iron elevation correlates with gait impairment severity.
Area of Science:
- Neuroimaging
- Neurology
- Biomedical Engineering
Background:
- Quantitative susceptibility mapping (QSM) shows increased iron in the basal ganglia of Parkinson's disease (PD) patients.
- The relationship between QSM findings and gait disturbances, such as freezing of gait (FOG), remains understudied in PD.
Purpose of the Study:
- To investigate the association between QSM-derived iron levels in basal ganglia and extra-basal ganglia structures and gait impairments in PD patients.
- To compare QSM values between PD patients and cognitively unimpaired (CU) individuals.
Main Methods:
- A case-control study involving 29 PD and 27 CU participants.
- Whole-brain QSM acquired at 3T, with manual region of interest (ROI) delineation in key brain structures.
- Comparison of ROI susceptibilities between groups and correlation with qualitative (FOG questionnaire) and quantitative gait measures.
Main Results:
- No significant differences in QSM susceptibility were found between PD and CU groups overall.
- PD patients with gait impairment exhibited higher susceptibility in the putamen, red nucleus, and caudate nucleus compared to those without gait impairment.
- PD patients with FOG showed significantly higher susceptibility in the globus pallidus compared to those without FOG.
Conclusions:
- Brain iron levels, as measured by QSM in basal ganglia and other structures, are linked to gait impairment and FOG in Parkinson's disease.
- QSM may serve as a potential imaging biomarker for gait disturbances in PD.

